Disrupting the Interplay between Programmed Cell Death Protein 1 and Programmed Death Ligand 1 with Spherical Nucleic Acids in Treating Cancer

[Image: see text] Disrupting the interplay between programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) is a powerful immunotherapeutic approach to cancer treatment. Herein, spherical nucleic acid (SNA) liposomal nanoparticle conjugates that incorporate a newly designed antis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Liyushang, Callmann, Cassandra E., Dominguez, Donye, Zhang, Bin, Mirkin, Chad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523766/
https://www.ncbi.nlm.nih.gov/pubmed/36188343
http://dx.doi.org/10.1021/acscentsci.2c00717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523766/
https://www.ncbi.nlm.nih.gov/pubmed/36188343
http://dx.doi.org/10.1021/acscentsci.2c00717

Ejemplares similares